US002 — Houston, Texas

US002 is a clinical research site located in Houston, Texas, United States.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

US002 has participated in 1 clinical trials.

Therapeutic areas: Dravet Syndrome.

Sponsors: H. Lundbeck A/S.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Houston

Browse all research sites in Texas · View every site in Houston

• The University of Texas MD Anderson Cancer Center /ID# 277929
• UT Health/ Memorial Hermann Hospital
• University of Texas Vanguard Urologic Research Foundation
• Anxiety and Health Research Lab, Substance Use Treatment Clinic, University of Houston
• Texas Children's Hospital West Campus
• The Methodist Hospital Houston
• The University Of Texas at Houston
• Houston Methodist Hospital - 6565 Fannin St
• Ben Taub General Hospital / Baylor College of Medicine/Harris Health System
• Lyndon B. Johnson Hospital (Site 1014), 5656 Kelley Street
• The Methodist Hospital Research Institute; Academic Office of Clinical Trials
• University of Texas Health Sciences Center at Houston - Center for Advanced Heart Failure

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US002?

US002 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US002 conducted?

US002 has 1 clinical trials on record. Their work covers Dravet Syndrome.

Is US002 accredited by Crixeo Clinical Trials?

US002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.